Title |
A CRISPR/Cas9-Engineered ARID1A-Deficient Human Gastric Cancer Organoid Model Reveals Essential and Nonessential Modes of Oncogenic Transformation
|
---|---|
Published in |
Cancer Discovery, January 2021
|
DOI | 10.1158/2159-8290.cd-20-1109 |
Pubmed ID | |
Authors |
Yuan-Hung Lo, Kevin S Kolahi, Yuhong Du, Chiung-Ying Chang, Andrey Krokhotin, Ajay Nair, Walter D Sobba, Kasper Karlsson, Sunny J Jones, Teri A Longacre, Amanda T Mah, Bahar Tercan, Alexandra Sockell, Hang Xu, Jose A Seoane, Jin Chen, Ilya Shmulevich, Jonathan S Weissman, Christina Curtis, Andrea Califano, Haian Fu, Gerald R Crabtree, Calvin J Kuo |
X Demographics
The data shown below were collected from the profiles of 48 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 25 | 52% |
Ireland | 2 | 4% |
Canada | 2 | 4% |
United Kingdom | 2 | 4% |
Colombia | 1 | 2% |
Japan | 1 | 2% |
Spain | 1 | 2% |
India | 1 | 2% |
Hong Kong | 1 | 2% |
Other | 0 | 0% |
Unknown | 12 | 25% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Scientists | 20 | 42% |
Members of the public | 17 | 35% |
Science communicators (journalists, bloggers, editors) | 7 | 15% |
Practitioners (doctors, other healthcare professionals) | 4 | 8% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 110 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 21 | 19% |
Researcher | 14 | 13% |
Student > Master | 11 | 10% |
Student > Doctoral Student | 6 | 5% |
Student > Bachelor | 5 | 5% |
Other | 6 | 5% |
Unknown | 47 | 43% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 32 | 29% |
Medicine and Dentistry | 12 | 11% |
Agricultural and Biological Sciences | 8 | 7% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 2% |
Business, Management and Accounting | 1 | <1% |
Other | 6 | 5% |
Unknown | 49 | 45% |
Attention Score in Context
This research output has an Altmetric Attention Score of 25. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 April 2023.
All research outputs
#1,543,953
of 25,734,859 outputs
Outputs from Cancer Discovery
#767
of 4,153 outputs
Outputs of similar age
#44,067
of 549,355 outputs
Outputs of similar age from Cancer Discovery
#47
of 156 outputs
Altmetric has tracked 25,734,859 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,153 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 22.2. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 549,355 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 156 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 69% of its contemporaries.